E-LIB Suche - Ergebnisse für: Buchwald, Ulrike K

1

P21 A Phase 3 randomized, double-blind, active comparator-c..:

Bruno, Christopher ; Buntinx, Erik ; Pelayo, Enrique...
JAC-Antimicrobial Resistance. 6 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

2

Immunogenicity of Current and Next-Generation Pneumococcal ..:

Feemster, Kristen ; Buchwald, Ulrike K ; Banniettis, Natalie...
Open Forum Infectious Diseases. 11 (2024) 5 - p. , 2024

Link: https://doi.org/10.1093/..

3

Safety, tolerability, and immunogenicity of an adult pneumo..:

Platt, Heather L ; Bruno, Christopher ; Buntinx, Erik...
The Lancet Infectious Diseases. , 2024

Link: https://doi.org/10.1016/..

4

Anal dysplasia and anal cancer screening practices among li..:

Moughames, Eric ; Abdi, Maaza ; Morris, Bridget...
Transplant Infectious Disease. , 2024

Link: https://doi.org/10.1111/..

5

Safety and Immunogenicity of V114 in Preterm Infants: A Poo..:

Chapman, Timothy J. ; Patel, Shrita M. ; Flores, Sheryl A....
Pediatric Infectious Disease Journal. 42 (2023) 11 - p. 1021-1028 , 2023

Link: https://doi.org/10.1097/..

6

An indirect treatment comparison (ITC) and matching-adjuste..:

Mt-Isa, Shahrul ; Chumbley, Justin R. ; Crawford, Emma L....
Expert Review of Vaccines. 22 (2023) 1 - p. 906-917 , 2023

Link: https://doi.org/10.1080/..

7

P07 A Phase 3 randomized, double-blind, comparator-controll..:

Wilck, Marissa ; Cornely, Oliver A ; Ljungman, Per...
JAC-Antimicrobial Resistance. 5 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1093/..

8

A phase I study of intra-anal artesunate (suppositories) to..:

Fang, Sandy Hwang ; Plesa, Mihaela ; Carchman, Evie H....
PLOS ONE. 18 (2023) 12 - p. e0295647 , 2023

Link: https://doi.org/10.1371/..

9

A Phase 3, Randomized, Double-Blind, Comparator-Controlled ..:

Wilck, Marissa ; Cornely, Oliver A ; Cordonnier, Catherine...
Clinical Infectious Diseases. 77 (2023) 8 - p. 1102-1110 , 2023

Link: https://doi.org/10.1093/..

10

PCV15, a pneumococcal conjugate vaccine, for the prevention..:

Chapman, Timothy J ; Olarte, Liset ; Dbaibo, Ghassan...
Expert Review of Vaccines. 23 (2023) 1 - p. 137-147 , 2023

Link: https://doi.org/10.1080/..

11

Phase 3 trial to evaluate the safety, tolerability, and imm..:

Hammitt, Laura L. ; Quinn, Dean ; Janczewska, Ewa...
Human Vaccines & Immunotherapeutics. 19 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

12

The 15-valent pneumococcal conjugate vaccine V114 induces c..:

Shi, Yaru ; Nolan, Katrina M. ; Burton, Robert L....
Human Vaccines & Immunotherapeutics. 19 (2023) 2 - p. , 2023

Link: https://doi.org/10.1080/..

13

Comment on Chandler et al. 23-Valent Pneumococcal Polysacch..:

Cossrow, Nicole ; Joshi, Rennie ; Klinker, Kenneth.
Microorganisms. 10 (2022) 10 - p. 1987 , 2022

Link: https://doi.org/10.3390/..

14

Lot-to-lot consistency, safety, tolerability, and immunogen..:

Simon, Jakub K. ; Staerke, Nina Breinholt ; Hemming-Harlo, Maria...
Vaccine. 40 (2022) 9 - p. 1342-1351 , 2022

Link: https://doi.org/10.1016/..

15

A phase 3 trial of safety, tolerability, and immunogenicity..:

Platt, Heather L. ; Cardona, Jose F. ; Haranaka, Miwa...
Vaccine. 40 (2022) 1 - p. 162-172 , 2022

Link: https://doi.org/10.1016/..